Folate receptor-targeted drugs for cancer and inflammatory diseases - Preface

[21] Toffoli G, 1997, INT J CANCER, V74, P193, DOI 10.1002/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO

[22] 2-F

[23] TUREK JJ, 1993, J CELL SCI, V106, P423

[24] DELIVERY OF ANTISENSE OLIGODEOXYRIBONUCLEOTIDES AGAINST THE HUMAN EPIDERMAL GROWTH-FACTOR RECEPTOR INTO CULTURED KB CELLS WITH LIPOSOMES CONJUGATED TO FOLATE VIA POLYETHYLENE-GLYCOL [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) : 3318 - 3322

[25] Ward CM, 2000, CURR OPIN MOL THER, V2, P182

[26] Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy [J]. JOURNAL OF CONTROLLED RELEASE, 2001, 74 (1-3) : 115 - 128

[21] Toffoli G, 1997, INT J CANCER, V74, P193, DOI 10.1002/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO

[22] 2-F

[23] TUREK JJ, 1993, J CELL SCI, V106, P423

[24] DELIVERY OF ANTISENSE OLIGODEOXYRIBONUCLEOTIDES AGAINST THE HUMAN EPIDERMAL GROWTH-FACTOR RECEPTOR INTO CULTURED KB CELLS WITH LIPOSOMES CONJUGATED TO FOLATE VIA POLYETHYLENE-GLYCOL [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) : 3318 - 3322

[25] Ward CM, 2000, CURR OPIN MOL THER, V2, P182

[26] Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy [J]. JOURNAL OF CONTROLLED RELEASE, 2001, 74 (1-3) : 115 - 128